Related Experiment Video
Updated: Jul 8, 2026

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
Published on: March 26, 2015
Relapsing demyelinating disease affecting both the central and peripheral nervous systems
H Zéphir1, T Stojkovic, P Latour
1Clinique Neurologique, Hôpital Roger Salengro, 59037 Lille Cedex, France. H-ZEPHIR@chru-lille.fr
This study identifies a novel inflammatory demyelinating disease affecting both the central and peripheral nervous systems. Its unique presentation suggests distinct pathogenic mechanisms differentiating it from multiple sclerosis and chronic inflammatory demyelinating polyradiculopathy.
Area of Science:
- Neuroimmunology
- Neurology
- Demyelinating Diseases
Background:
- Chronic inflammatory demyelinating polyradiculopathy (CIDP) and multiple sclerosis (MS) share some clinical and electromyographic findings.
- Distinguishing these conditions from other demyelinating diseases is crucial for accurate diagnosis and treatment.
Observation:
- Five patients presented with a relapsing-remitting demyelinating disease affecting both the central nervous system (CNS) and peripheral nervous system (PNS).
- CNS involvement consistently preceded PNS involvement in all cases.
- Patients met diagnostic criteria for MS and, in some cases, CIDP, but lacked oligoclonal bands and showed peripheral demyelination without conduction block.
Findings:
- The study identified a unique demyelinating disease impacting both CNS and PNS.
- Electromyography revealed peripheral demyelination without conduction block, distinguishing it from typical CIDP.
- Histological findings in nerve biopsies were consistent with CIDP, despite differing clinical and neurophysiological profiles.
Implications:
- The distinct presentation suggests novel pathogenic mechanisms, potentially involving immunological reactivity to shared central and peripheral myelin antigens.
- This entity is unlike MS, CIDP, or acute demyelinating encephalomyelitis.
- Understanding this disease expands the spectrum of demyelinating disorders and informs future diagnostic and therapeutic strategies.
More Related Videos
08:17Scoring Central Nervous System Inflammation, Demyelination, and Axon Injury in Experimental Autoimmune Encephalomyelitis
Published on: February 23, 2024
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Related Concept Videos
Multiple Sclerosis l: Introduction
Encephalitis ll: Pathophysiology
Arboviral Encephalitis
Disorders of the Nervous Tissue
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Diphtheria
Encephalitis l: Introduction